Global Continuous Subcutaneous Insulin Infusion Devices Market Research Report 2021

1 Continuous Subcutaneous Insulin Infusion Devices Market Overview

• 1.1 Product Overview and Scope of Continuous Subcutaneous Insulin Infusion Devices
• 1.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
  • 1.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Normal Pump
  • 1.2.3 Patch Pump
• 1.3 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
  • 1.3.1 Continuous Subcutaneous Insulin Infusion Devices Sales Comparison by Application: (2021-2027)
  • 1.3.2 Type I Diabetes
  • 1.3.3 Type II Diabetes
• 1.4 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Estimates and Forecasts
  • 1.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue 2016-2027
  • 1.4.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales 2016-2027
  • 1.4.3 Continuous Subcutaneous Insulin Infusion Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Continuous Subcutaneous Insulin Infusion Devices Market Competition by Manufacturers

• 2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Continuous Subcutaneous Insulin Infusion Devices Manufacturing Sites, Area Served, Product Type
• 2.5 Continuous Subcutaneous Insulin Infusion Devices Market Competitive Situation and Trends
  • 2.5.1 Continuous Subcutaneous Insulin Infusion Devices Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Continuous Subcutaneous Insulin Infusion Devices Players Market Share by Revenue
  • 2.5.3 Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Continuous Subcutaneous Insulin Infusion Devices Retrospective Market Scenario by Region

• 3.1 Global Continuous Subcutaneous Insulin Infusion Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Continuous Subcutaneous Insulin Infusion Devices Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
  • 3.3.1 North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country
  • 3.3.2 North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
  • 3.4.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country
  • 3.4.2 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region
  • 3.5.2 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
  • 3.6.1 Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country
  • 3.6.2 Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country
  • 3.7.2 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Continuous Subcutaneous Insulin Infusion Devices Historic Market Analysis by Type

• 4.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2016-2021)
• 4.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2016-2021)
• 4.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2016-2021)

5 Global Continuous Subcutaneous Insulin Infusion Devices Historic Market Analysis by Application

• 5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2016-2021)
• 5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2016-2021)
• 5.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Medtronic
  • 6.1.1 Medtronic Corporation Information
  • 6.1.2 Medtronic Description and Business Overview
  • 6.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Medtronic Product Portfolio
  • 6.1.5 Medtronic Recent Developments/Updates
• 6.2 Roche
  • 6.2.1 Roche Corporation Information
  • 6.2.2 Roche Description and Business Overview
  • 6.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Roche Product Portfolio
  • 6.2.5 Roche Recent Developments/Updates
• 6.3 Insulet Corp
  • 6.3.1 Insulet Corp Corporation Information
  • 6.3.2 Insulet Corp Description and Business Overview
  • 6.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Insulet Corp Product Portfolio
  • 6.3.5 Insulet Corp Recent Developments/Updates
• 6.4 Tandem Diabetes care
  • 6.4.1 Tandem Diabetes care Corporation Information
  • 6.4.2 Tandem Diabetes care Description and Business Overview
  • 6.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Tandem Diabetes care Product Portfolio
  • 6.4.5 Tandem Diabetes care Recent Developments/Updates
• 6.5 Valeritas
  • 6.5.1 Valeritas Corporation Information
  • 6.5.2 Valeritas Description and Business Overview
  • 6.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Valeritas Product Portfolio
  • 6.5.5 Valeritas Recent Developments/Updates
• 6.6 SOOIL
  • 6.6.1 SOOIL Corporation Information
  • 6.6.2 SOOIL Description and Business Overview
  • 6.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 SOOIL Product Portfolio
  • 6.6.5 SOOIL Recent Developments/Updates
• 6.7 Microport
  • 6.6.1 Microport Corporation Information
  • 6.6.2 Microport Description and Business Overview
  • 6.6.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Microport Product Portfolio
  • 6.7.5 Microport Recent Developments/Updates

7 Continuous Subcutaneous Insulin Infusion Devices Manufacturing Cost Analysis

• 7.1 Continuous Subcutaneous Insulin Infusion Devices Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
• 7.4 Continuous Subcutaneous Insulin Infusion Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Continuous Subcutaneous Insulin Infusion Devices Distributors List
• 8.3 Continuous Subcutaneous Insulin Infusion Devices Customers

9 Continuous Subcutaneous Insulin Infusion Devices Market Dynamics

• 9.1 Continuous Subcutaneous Insulin Infusion Devices Industry Trends
• 9.2 Continuous Subcutaneous Insulin Infusion Devices Growth Drivers
• 9.3 Continuous Subcutaneous Insulin Infusion Devices Market Challenges
• 9.4 Continuous Subcutaneous Insulin Infusion Devices Market Restraints

10 Global Market Forecast

• 10.1 Continuous Subcutaneous Insulin Infusion Devices Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Type (2022-2027)
• 10.2 Continuous Subcutaneous Insulin Infusion Devices Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Application (2022-2027)
• 10.3 Continuous Subcutaneous Insulin Infusion Devices Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List